The kind of interactions which nanoparticles show in the biological systems is very interesting. Nanoparticles (NPs) on entering the living system immediately come in contact with proteins which serve many applications of nanoparticles including bio-signalling, therapeutics and drug delivery systems. Moreover, many inorganic oxide nanoparticles can also serve the purpose of antibacterial/antiviral by assisting in the production of reactive oxygen species (ROS). The role of nanoparticles in therapeutics is very significant and increasing day-by-day as it assures better treatment to the patient by enhancing activity of drug, improving bioavailability, flexibility in deciding route of administration and long term stability of drug resulting in better treatments of diseases. NPs such as solid lipid NPs, polymeric NPs, porous NPs, liposomes are being used for treatment of various types of diseases. Numerous carriers based drug delivery systems incorporating anti-TB drugs have been developed for target site actions. NPs encapsulating anti-cancer drugs such as doxorubicin, paclitaxel have also been developed for treatment of different types of cancers. Results of these studies give hopes to the researchers for the use of nanoparticles in the field of therapeutics. The NPs can be toxic as well as nontoxic to the biological system. Therefore, some adverse effects, such as, cytotoxicity on inhaling some kinds of nanoparticles must be kept in mind for judicious use of such systems during synthesis or during handling. The paper describes recent developments in the field by reviewing the available literature.
Introduction
Nanoparticles (NPs) in biological systems, is a very innovative idea. Nanotechnology is not new; NPs were used by artisans dated as far as 9 th century to generate glittering effects on the pots. More interest in nanotechnology is growing due to the novel properties of nanomaterials and their potentials for applications in many fields. For example, nanowires can be potentially used in nanophotonics, lasers (Zimmler et al., 2008) , nanoelectronics (Javey et al., 2007) , solar cells (Tsakalakos et al., 2007) , resonators (Tanner et al., 2007) and sensors (Fan et al., 2005) . They could also be used as catalysts (Haruta et al., 1993) , functional coatings, in nanoelectronics (Garnett et al., 2007) and energy storage . Nanostructured thin films can also be used in light emitting devices, displays and high efficiency photovoltaics.
Recently, it has come to light that these can be engineered and exploited for various applications in biomedical field, diagnostics, therapeutics, drug delivery imaging and bio-signalling (Ghosh et al., 2008; Sperling et al., 2008; Hanley et al., 2008; Seo et al., 2006; Visaria et al., 2006) . 'Nanoparticles' (NPs) are the particles which range in nanosize usually from 1 -100 nm. As NPs can be engineered to be very small and hence comparable to many biomolecules present in in vivo systems, this provides ample opportunities for them to enter the living systems including cells and bacteria, and interact with biomolecules through various possible metabolism pathways. Once NPs enter a living system, various proteins adsorb to the surface giving rise to 'corona' (Lynch et al., 2008) . And even if they are not small enough to enter inside the living cell they still could form bonding with the cell membrane due to surface defects.
NPs could be structured in various shapes and sizes such as, solid spheres, hollow spheres, nanorods, nanotube and many other types of shapes by the same method of synthesis by varying process parameters or preparing by different methods or by giving heat treatments (Sahare et al., 2010; Rani et al., 2013) . It has also been found that these particles interact differently with proteins due to different shape of the 'corona' that they form. Nanorods consist of flat surfaces whereas NPs consist of spherical curvatures. It has been shown several times that as we move from nearly flat surface to curved one, there is gradual change in the type of interaction that protein shows at the surface . The activity and organisation of protein has been thus observed to change with the change in shape and size of a nanomaterial. For example, experiments have shown that in presence of gold nanorods, protein like bovine serum albumin (BSA) shows a loss in its native structure which results in loss of its activities whereas in presence of gold NPs, it retains most of its structure and activities Joshi et al., 2011) . The use of nanoparticles also overcomes the limiting case of flat surfaces which affect biological processes only via cell receptors as NPs can enter inside of the cell and interact with various cellular ingredients through different mechanisms and metabolisms.
Also the extent of adsorption on NPs depends on the degree of curvature that is surface area/volume ratio, as the degree of curvature of NPs increases with decreasing size. It is also interesting to note that as size of NPs becomes very small, it can also show selective protein adsorption, especially, towards large proteins and hence gives us control of the protein to be adsorbed (Klein et al., 2007) . But since most NPs are not 'so small' (of the order of a few nm range), nearly all proteins present in the cell interact with the NPs and role of enzyme kinetics then comes 9 into play. In simple words, 'corona', a dynamic layer of proteins, that shows reversible binding to NPs and as a result they have different affinities towards NPs resulting in different 'time of residence' for different proteins at the NPs surfaces. Moreover, this corona doesn't reach the equilibrium immediately after entering the NPs in to the biological systems. Rather its final state is dependent on kinetic equilibrium in constants to proteins. Finally, proteins having higher affinity, slower exchange rate and lower concentrations may occupy the surfaces of NPs .
One important thing to be mentioned here is that even when the nanoparticle is covered by a dynamic layer of proteins, the biological and cellular systems see the 'corona' as the biological identity of the NPs. Therefore, what matters to the biological systems are not the NPs per se but the 'corona' (Lynch et al., 2006; Norde et al., 1991; Gray et al., 2004) . This dynamic layer (corona) also proves advantageous in movement of NPs from one cell to another, such as diffusing in a cell via blood stream. The concept of 'corona' is further strengthened by the studies showing that Bovine serum albumin (BSA), myoglobin (Mb) and cytochrome C (CytC) are adsorbed on NPs consisting of both reversibly and irreversibly adsorbed fractions. Further concept of hard and soft corona comes into picture where hard corona consists of strongly adsorbed proteins with larger residence times and soft corona consisting of proteins with low affinities and shorter residence times (Kaufman et al., 2007) .
It has also been found that formation of corona is either entropy or enthalpy driven or both. The increase in entropy is suggested to be a result of release of bound water from the surface of particles which is more than the reduction in entropy by the binding of proteins. Further note that it has been found that entropy driven binding does not result in conformational change of the protein (Vertegel et al., 2004; Shang et al., 1991; Lindman et al., 2007; Lacerda et al., 2010) .
The main advantage of using NPs comes into play when they are 'small enough' (the size of the particle is of the order of a few nm) to be called as quantum dots (QDs) and display quantum mechanical properties, specifically, its excitons are confined in all three spatial dimensions. These QDs have found applications in 'in vivo' imaging, bio-signalling and effective drug delivery. The NPs can be toxic as well as nontoxic to biological systems. The NPs upon binding with the proteins can be toxic owing to the change in the conformation and native structure of the proteins (Shen et al., 2007; Sabatino et al., 2007; Norde et al., 2000; Lewis et al., 1971) and hence leading to reduction in the activity of the protein rendering the protein unable to participate in metabolism pathways which it earlier used to. This property of certain NPs has also found applications especially those targeted against cancer cells and activated human T cells (Zhou et al., 2006; Liong et al., 2008) . Some QDs of inorganic oxides, especially, metal oxides, have also been found to show antibacterial/bactericidal activity. Most preferred nanoparticles are Zinc Oxide (ZnO) NPs due to their unique physical and chemical properties. The distinguished property of ZnO NPS is to generate reactive oxygen species (ROS) which makes it possible to act as an antimicrobial agent (Szabo et al., 2003; Singla et al., 2009; Gupta et al., 2006; Kuo et al., 2009) . The surface defects present on the surface of ZnO usually pick up anionic species depending on the synthesis route or on giving annealing treatments . If these anionic species are good electron donors, they can easily donate free electrons to oxygen present in the biological system once excited. This oxygen and free electrons through a chain of reactions lead to the formation of hydrogen peroxide which causes oxidative stress on lipids and if the concentration of ZnO exceeds a given amount then it leads to peroxidation of lipid, ultimately leading to its breakdown. They basically act as catalysts and do not take part directly in the process Kumar et al., 2013) . The catalytic process could be explained through the set of following chemical equations:
Following that NPs get internalized which then consequently results in oxidative DNA damage (Joshi et al., 2009; Premanathan et al., 2011) . This kind of production of ROS has been observed in all types of living systems. As the anionic species adsorbed to the surface of NPs depend on the synthesis route, we may control whether to increase or decrease the electron transfer capabilities of NPs to oxygen and thus releasing ROS.
NPs have diverse role in the field of science; these technologies give better opportunity to the researchers to find its best use in field of therapeutics, bio-signalling, drug delivery and many more.
Researchers are focussing on therapeutical use of NPs to reduce treatment duration, flexibility in choosing administration route and for enhancing the activity of drugs, so that the drugs can be used even in case of deadly diseases like Tuberculosis (TB) Meena et al., 2010; Meena et al., 2013) and cancer (Park, et al., 2002; Hanley, et al., 2008; Premanathan, et al. 2011 ).
Tuberculosis and cancer targeting Nanoparticles
TB is an extremely contagious chronic granulomatous bacterial infection. It is one of the leading causes of mortality and morbidity globally. TB is caused by Mycobacterium tuberculosis (MTB) which infects about one third of world's population and is accountable for approximately 9 million new cases of active TB and 1.7 million deaths yearly. Tubercle bacilli are acid fast, slender, grampositive non-motile bacilli. TB infection is generally initiated by the access of bacilli to the respiratory system in aerosol droplets Singh et al., 2011; Rajni et al., 2011) . These bacteria engulfed by alveolar macrophages that process the bacterial antigens and present them to lymphocytes T (Smith et al., 2003) . Then these bacilli augment exponentially by invading host cells and spread locally to regional lymph nodes in the lungs by lymphatic circulation (3-8 weeks post infection). Afterwards, the bacilli get disseminated to distantly situated organs like central nervous system, kidneys, liver, genitalia and more (3 months post infection). This leads to acute TB meningitis, which can result in fatality. In spite of having availability of effective treatment of TB, cure rates are very low and hence makes this disease the leading cause of avoidable deaths worldwide. The most effective pharmacotherapy consists of a multi-drug combination of first line drugs; these are Isoniazid (INH), Pyrazinamide (PZA), Rifampicin (RIF). Along with Ethambutol (EMB), all these drugs are administered during initial intensive stage (2 months) (Onyebujoh et al., 2005; W.H.O et al., 2013) . The second stage of about 4 months consists of RIF and INH. Streptomycin together with these 4 drugs (i.e., INH, RIF PZA and EMB) constitutes the first line therapy. The duration of treatment stems from the existence of antibiotic resistant non-metabolising bacteria and from the stationary or proliferating phase pathogens in old lesions or inside fibrotic or calcified sites (Rook et al., 1996) . Long treatment duration and the load of medication can hamper patients' 'standard of living' and thus add to their low compliance, therapeutic breakdown and more importantly, it becomes the central reason for emergence of drug resistant strains (Dye et al., 2006) . Administration of PZA along with second line drugs such as ethionamide, prothionamide, cycloserine, capromycin, p-aminosalicyclic acid or fluoroquinolones is normally favoured for treating the multi-drug resistant TB Mukherjee et al., 2004) . Second line drugs are less effective, more toxic, and more expensive than the first line drugs. And to assure therapeutic effectiveness, these drugs are administered for longer duration (9-12 months) resulting in patient's non-compliance (Smith et al., 2003) . Novel drugs employing NPs are particularly designed to overcome drug resistance; for shortening the treatment duration and to reduce drug interactions with the other anti-retroviral therapies. Such pharmaceutical techniques focus on improving the effectiveness of drug by targeting the infection reservoirs; enhancing patient's compliance and adherence. Cancer is another leading disease in both developed as well as developing countries. About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008. Emergence of nanotechnologies appears to be the most promising approaches in the field of therapeutics as drug delivery systems (Gelperina et al., 2005; Pison et al., 2006) . NPs are very effective materials for targeted drug delivery due to their capability to travel in bloodstream for moderately longer period of time as well as their ability to mount up in tumour spaces. Drug loaded NPs get endocytosed by the cells and then they are degraded to release drugs as shown in Figure 1 . Various forms of NPs are used for drug delivery such as nanosuspensions, nanoemulsions, niosomes, polymeric and non-polymeric NPs, polymeric micelles, dendrimers and liposomes. Nanosuspensions are sub-micron colloidal dispersions of pure drug stabilised with surfactants (Rabinow et al., 2004) . Nanonisation is a technique in which standard size of solid drug particles are compacted to nano-scale by top-milling or grinding. It is a very valuable technique to improve the solubility of drugs showing strong solute-solute communications and high melting points. Clofazimine is a riminophenazine compound having low solubility (0.3µg/ml) and high toxicity. Peter and collaborators formulated clofazimine nano-suspension (Peters et al., 2000) . They compared the effectiveness of clofazimine nanosuspension in treatment of murine Mycobacterium avium infected to that of drug loaded liposomes. Application of alternating discontinuous and continuous homogenisation process (10 cycles) resulted in 600 nm and 300 nm particles, both of which are powerful in capillary obstruction. In the study, at 100 nm clofazimine loaded liposomes showed pre-clinical effectiveness. Nanosuspensions displayed more homogeneous size distribution and physical stability for longer duration of time. In vivo assays were conducted with nano formulations consisting drug concentration ranging 0.16% to 0.18%. Findings of these assays showed that the drug (clofazimine) concentration above MIC of pathogen was 81.4, 72.5 and 35.0 mg/kg in the tissues of spleen, liver and lung, respectively, following the administration of NPs. Liposomal clofazimine and clofazimine nanosuspension had comparable effectiveness; however, the ease of preparation and physical stability of clofazimine nanosuspension were distinguishing.
Recently, Wang et al. developed poly-(ethylene glycol) modified docetaxel lipid based nanosuspension (pLNS) and targeted docetaxel lipid based nanosuspensions (tLNS) having folate as target ligand, for drug delivery to the human hepatocellular liver carcinoma HepG2 (FR-) and B16 (FR+). pLNS was developed to augment duration of drug within body and to increase the accumulation of drug at target site whereas tLNS designed to target the tumour cells that overexpressed folate receptor (FR).
The in vivo study results showed that tLNS exhibits high tumour efficacy than pLNS and Duopafei by reducing tumour volume and the biodistribution study showed that tLNS activity was due to increase in accumulation of drug in tumour (Wang et al., 2012) .
Nanoemulsions are thermodynamically stable oil-droplets dispersed in water (drop size between 10 and 100 nm, e.g., Constantinides et al., 2008) . These nanoemulsions can be formed spontaneously and in large scale without the need of homogenisation energy. Nanoemulsions can be filter sterilised. The extent of nanoemulsions uptake by phagocytic cells reported elsewhere renders passive targeting features of the nanoemulsions (Seki et al., 2004) . Moreover, nanoemulsions are uptaken by lipoprotein receptors in liver (Singh et al., 2008) . Talekar et al. checked the anti-cancer activity of PIK75 (Phosphatidylinositol 3-kinase Inhibitor) incorporated in surface functionalised nanoemulsions for targeted delivery to SKOV-3 cells (Ovarian cancer). The study showed that targeted system improved cytotoxicity of PIK75 compared to the non-targeted system. Ceramide enhanced the PIK75's therapeutic activity in combinational therapy. Another study reported the formulation of filter sterilisable emulsion of paclitaxel using α-tocopherol as oil phase and α-tocopherol poly-ethylene glycol-1000 succinate and poloxamer as emulsifier. The results showed that formulation exhibited better efficacy and was more tolerable when studied in B16 melanoma tumour model in mice (Talekar et al., 2012) .
Niosomes are thermodynamically stable liposomes. These are composed of non-ionic surfactant (like monoalkyl or dialkyl polyoxyethylene ether) and cholesterol with subsequent hydration in aqueous media. Niosomes proved to be effective and better drug delivery systems than liposomes 13 in case of sterilisation, high production costs, scale-up difficulties and the instability of phospholipidic components due to light exposure even at room temperature. Niosomes hold hydrophilic drugs within core and lipophilic ones by entrapment in hydrophobic domains (Sosnik et al., 2010) . In a study, Jain and Vyas generated RIF loaded niosomes of micro size, 8-15 µm along with Span 85 as surfactant (Jain et al., 1995) . In vivo studies showed that the localisation of up to 65% drugs occurred in lungs by altering the size of niosomes. The same group of scientists conducted a study to investigate and evaluate the biodistribution of niosomes with smaller sizes (1-2 µm) produced with different Sorbitan esters and cholesterol in a 50:50 percent mole fraction ratio . The study conducted showed that more lipophilic the surfactant the slower is the drug release in aqueous medium. Considerable higher RIF concentration in thoracic lymph nodes attained by niosomes via the intra-peritoneal route (46.2% of total administered dose) opposed to 13.1% for free drug suggesting more compartmentalisation of drug in lymphous tissues. In contrast, when drug loaded niosomes were injected intravenously, only 7.3% of drug was found in thorax with lower accumulation extent as compared to 11.5% of the free drug.
Polymeric nanoparticles are of significant importance in drug solubilisation, stabilisation and targeting. Polymeric NPs consists of two kinds of systems according to their method of generation, these are nanocapsules and nanospheres. In case of nanocapsules, drug solubilised in aqueous or oily solvents is surrounded by a polymeric membrane whereas nanospheres consists of solid matrices of variable porosity in which the drug particles are homogeneously distributed through the NPs and frequently, dispersed at molecular level [60] . Polymeric NPs include those made from chitosan, gelatine, PBCA [poly-(n-butylcyanoacrylate)], PIBCA [poly-(isobutylcyanoacrylate)], and PLGA [poly-(lactic-co-glycolic acid)]. High stability, high loading capacity for hydrophilic and hydrophobic drugs and possibility of administration via different routes are advantageous features of polymeric NPs for their use in drug encapsulation (Brannon-Peppas et al., 1995) . Polymeric NPs have been one of the most studied particles with respect to anti-TB drug delivery systems. Anisimova et al. used PBCA and PIBCA NPs for encapsulation of RIF, INH and Streptomycin and investigated the accumulation in human blood monocytes in vitro toward the development of drug depository (Anisimova et al., 2000) . All these encapsulated drugs showed a detectable increase in intracellular concentration with respect to extracellular concentration [i.e., 4 to 8 fold increase for INH, 7 fold for Streptomycin and 22 to 25 fold increase for RIF], whereas, free drugs INH and RIF showed similar to and 5 fold higher intracellular concentration than the extracellular concentration. Streptomycin, however, was not detectable. Pandey et al. developed sustained release RIF, INH and PZA loaded poly-(lactide-co-glycolide) NPs for oral delivery in mice. As a result, the drugs were detected in plasma for up to 4 days for RIF and 9 days for INH and PZA; whereas in tissues, drugs were detected till 9 to 11 days after single oral administration of NPs and free drugs were cleared within 12-24 hours from plasma. For complete bacterial clearance only 5 doses of drug loaded NPs were sufficient while for free drugs 46 doses needed to get the same result (Pandey et al., 2003) . In another study, doxorubicin conjugated glycol chitosan (DOX-GC) with cis-aconityl spacer was generated by chemical attachment of N-cis-aconityl DOX to GC by using carbodiimide. In aqueous condition, DOX-GC conjugates containing 2-5 wt% DOX form selfassembled NPs but if DOX is above 5.5 wt% then the DOX-GC conjugates get precipitated due to increase in hydrophobicity. The release rate of DOX from NPs is dependent on pH of media because cis-aconityl spacer is cleavable at low pH values. When DOX-GC conjugated NPs were administered into mice, they get accumulated in tumour site showing enhanced permeability and retention effect (EPR effect, Ohya et al., 1994) . For better clarity EPR-effect has been shown in Fig. 2 . Gallo et al. generated magnetic chitosan microspheres containing oxantrazole (MCM-OX) for treatment of brain tumour. He observed the level of OX concentration in brain after administrating intra-arterial injections of MCM-OX to Fischer 344 male rats under magnetic field for 30 minute. A 100 fold increase in OX concentration in brain was observed as compared to OX in solution (Zhou et al., 2009) .
Fig. 2.
Nanoparticles showing enhanced permeation and retention effect to target the cancer cells.
Polymeric micelles are nanoscopic structures formed by self-assembly of amphiphilic polymers in water above the critical micelle concentration (CMC, Kataoka et al., 2001) . Micellar shells are formed by hydrophilic blocks that are exposed to aqueous medium, micellar shells facilitate the solubilisation of amphiphile in water and thus stabilise aggregates. In contrast, hydrophobic blocks form the inner micellar core, a hydrophobic domain, which facilitates the incorporation of poorly water soluble drugs by physical interaction or chemical conjugation leading to higher solubility extents (Croy et al., 2006) . PEO-PPO [poly-(ethylene oxide)-poly-(propylene oxide)] block copolymers (linear poloxamers and branched poloxamines) are some of the significant commercially available micelle forming materials approved by Food and Drug Administration (Chiappetta et al., 2007) . Polymeric micelles are more stable than the conventional micelles even at concentration below CMC (Sosnik et al., 2010) . Zahroor et al. used ionotropic gelation method for preparing alginate NPs (235 nm) loaded with anti-TB drugs. Oral administration of drugs to mice resulted in detection of free drugs concentration in tissues till next day, while in plasma alginate NPs were detected up to 7 days for ETB, 9 days for RIF, 11 days for INH and 15 days for PZA in tissues (Zahoor et al., 2006) . Silva et al. aimed to attain high effectiveness and longer anti-TB activity while limiting the toxic effect so they generated INH loaded poly-(ethylene glycol)-poly-(aspartic acid) conjugates that sustain the release of drugs overtime as compared to the free drug.
INH loaded pro-drug showed a 5.6 fold increase in activity against M. tuberculosis (MTB) (Silva et al., 2001 ).
Dendrimers are macromolecules displaying structural perfection; these are regularly hyperbranched, 3-dimensional, relatively low molecular weight, polydispersity and adjustable functionality (Sosnik et al., 2010 Liposomes are composite structures of nano to micro sizes consisting of a phospholipid bilayer that surrounds an aqueous core (Gregoriadis et al., 1974 ). Liposome's core can encapsulate water soluble drugs while the hydrophobic domain can entrap the insoluble agents (Sosnik et al., 2010) , Fig. 3 . Liposome formulations are targeted to reduce toxicity and to enhance accumulation at the target site. On administration, liposomes are recognised by phagocytic cells and are cleared from blood stream. To prevent elimination and to extend circulation times, liposomes are generally PEGylated. Deol and Khuller generated lung specific liposomes consisting of phosphatidylcholine, cholesterol, dicetyl phosphate, o-steroyl amylopectin and monosialogangliosides/ distearyl phosphatidyl ethanolamine-poly-(ethylene glycol) 2000 for targeted delivery of anti-TB drugs (Deol et al., 1997) . A study showed the increase from 5.1% for conventional liposome to 31% for PEGylated systems containing o-steroyl amylopectin in the accumulation of NPs after 30 minutes in lungs. The extent of NPs accumulation was associated with the composition. The uptake levels rose up to 40% for modified liposomes after 30 minutes in lungs as compared to conventional liposomes. Moreover, conventional liposomes saturated the reticulo-endothelial system when administered in both healthy and infected animals, 1 hour prior to modify liposome administration. Modified liposomes showed reduction in the uptake and accumulation in liver and spleen. The extent of drug incorporation was 8-10% for INH and 44-49% for RIF. The cytotoxicity of drug loaded liposomes was also tested showing a significant decrease in toxicity in peritoneal macrophages as compared to free drugs. Anti-HER2 monoclonal antibody (Mab) loaded liposomes composed of phosphatidylethanolamine and polyethylene glycol (PEG) modified distearoyl phosphatidylethanolamine with average particle diameter of 100 nm has resulted in enhanced antitumour efficacy of doxorubicin over the different control formulations (Park et al., 2002) . 
Concluding Remarks
Our core hypothesis is that, NPs have high curvature and sizes similar to biomolecules and can be exploited for our advantages. On entering the biological systems, NPs interact with proteins and form 'corona'. That is the way a cell sees NPs. Thus, NPs can enter the biological system and thus, can be engineered to manipulate various metabolism processes. Hence, NPs have found biomedical and biological applications such as drug delivery, bio signalling and in vivo imaging. Furthermore, NPs of metal oxides can be used as antibacterial/bactericidal and also their surfaces can be modified to serve as a drug delivery system. They are already being used against various types of cancers and in TB treatments. NPs technologies in the field of therapeutics have resulted in better treatment, short duration and better management. As the 21 st century advances, more applications of NPs in biological system will be discovered. However, the adverse effects of the nanostructured materials like cytotoxicity should also be kept in mind before employing them for various applications for the betterment of the mankind.
